	Ebit		Date
Abbott	USD 2.54B	358M	2025-12
Agenus	USD -13.31M	19.08M	2025-03
Agios Pharmaceuticals	USD -121.58M	4.71M	2025-12
Anika Therapeutics	USD -4.28M	3.58M	2025-03
Arrowhead Research	USD 40.81M	17.01M	2025-12
Enanta Pharmaceuticals	USD -23.54M	6.31M	2024-12
Halozyme Therapeutics	USD -88.41M	306.33M	2025-12
Heron Therapeutics	USD -4.46M	5.76M	2024-09
Insmed	USD -249.71M	11.64M	2025-12
Integra LifeSciences	USD 66M	54.24M	2025-12
Intrexon	USD -26.3M	2.91M	2024-06
J&J	USD 5.11B	2.3B	2025-12
Karyopharm Therapeutics	USD -26.28M	1.84M	2024-09
Ligand Pharmaceuticals	USD 158.89M	115.32M	2025-09
MacroGenics	USD 20.16M	55.51M	2025-09
Merit Medical Systems	USD 54.2M	11.58M	2025-12
Rigel Pharmaceuticals	USD 447K	1.52M	2024-06
Sanofi	EUR 1.7B	2.17B	2025-12
Smith & Nephew	USD 440M	50M	2025-12
Stryker	USD 1.97B	609M	2025-12
Surmodics	USD -322K	2.13M	2023-12
Veracyte	USD 24.63M	1.52M	2025-12
Xencor	USD -53.63M	6.11M	2025-12
Zimmer Biomet Holdings	USD 302.9M	35.4M	2025-12

Anika Therapeutics - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.